Clinical characteristics and outcomes of 11 neonates with venous thrombosis.
10.7499/j.issn.1008-8830.2410110
- Author:
Xi-Ge GU
1
;
Li-Ying DAI
1
;
Xiao-Qing SHI
1
;
Wen-Chao ZHANG
1
;
Yong-Li ZHANG
1
Author Information
1. Children's Medical Center of Anhui Medical University/Fifth Clinical Medical College of Anhui Medical University/Department of Neonatology, Anhui Children's Hospital, Hefei 230000, China.
- Publication Type:Journal Article
- Keywords:
Anticoagulation;
Neonate;
Thrombolysis;
Treatment outcome;
Venous thrombosis
- MeSH:
Humans;
Male;
Venous Thrombosis/drug therapy*;
Infant, Newborn;
Female;
Retrospective Studies
- From:
Chinese Journal of Contemporary Pediatrics
2025;27(5):588-594
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To summarize the clinical characteristics, diagnosis, and treatment outcomes of neonatal venous thrombosis.
METHODS:A retrospective analysis was conducted on the clinical data of 11 neonates with venous thrombosis admitted to the Department of Neonatology of Anhui Children's Hospital from January 2019 to September 2024. The clinical characteristics, diagnostic approaches, treatments, and outcomes were analyzed.
RESULTS:Among the 11 neonates diagnosed with venous thrombosis, 5 were male, and 6 were preterm infants, with a median gestational age of 35+6 weeks, birth weight of (2 322±1 069) g, and admission temperature of (36.6±0.4)°C. The median age at symptom onset was 6 days. Of the 11 cases, 8 limb venous thromboses and 1 portal vein thrombosis were confirmed by vascular ultrasound, and 2 cases of intracranial venous sinus thrombosis were confirmed by magnetic resonance imaging. Ten cases received low molecular weight heparin for anticoagulation, with a treatment duration of (24±15) days; 2 cases were treated with urokinase thrombolysis, and 4 cases received fresh frozen plasma transfusion. Thrombosis resolved in 7 cases before discharge. Partial resolution occurred in 2 cases before discharge (1 continued outpatient treatment until resolution and 1 resolved during follow-up). One case was transferred to another hospital after 1 day of treatment and was discharged after thrombosis reduction. No adverse reactions such as bleeding were observed. One neonate with cerebral infarction at admission did not receive heparin anticoagulation and was followed up as an outpatient.
CONCLUSIONS:Vascular ultrasound is the most commonly used diagnostic method for neonatal venous thrombosis. Heparin anticoagulation is the recommended treatment. The overall prognosis of neonatal venous thrombosis is favorable.
